HCPCS Level II
J9209
Injection, mesna, 200 mg
Codes near J9209
These sit next to J9209 in the CMS Level II file. All J codes
- J9204Injection, mogamulizumab-kpkc, 1 mg
- J9205Injection, irinotecan liposome, 1 mg
- J9206Injection, irinotecan, 20 mg
- J9207Injection, ixabepilone, 1 mg
- J9208Injection, ifosfamide, 1 gram
- J9210Injection, emapalumab-lzsg, 1 mg
- J9211Injection, idarubicin hydrochloride, 5 mg
- J9212Injection, interferon alfacon-1, recombinant, 1 microgram
- J9213Injection, interferon, alfa-2a, recombinant, 3 million units
- J9214Injection, interferon, alfa-2b, recombinant, 1 million units
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00143-9260-01 | Mesna | Hikma Pharmaceuticals USA Inc. | 5 |
| 00338-1305-01 | Mesnex | Baxter Healthcare Corporation | 5 |
| 10019-0953-01 | Mesna | Baxter Healthcare Corporation | 5 |
| 25021-0201-10 | Mesna | Sagent Pharmaceuticals | 5 |
| 25021-0201-11 | Mesna | Sagent Pharmaceuticals | 50 |
| 63323-0733-11 | Mesna | FreseniUS Kabi USA, LLC | 5 |
| 70860-0209-10 | Mesna | Athenex Pharmaceutical Division, LLC | 5 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.